Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syndrome of Inappropriate Antidiuresis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02009878
What this trial is testing

A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Who this might be right for
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Not applicableStudy completedNCT05055856
What this trial is testing

Asymptomatic Bacteriuria, Hyponatremia and Geri-atric Syndrome

Who this might be right for
Asymptomatic BacteriuriaFrailtyGeriatric Syndrome+1 more
Universitair Ziekenhuis Brussel 36
Large-scale testing (Phase 3)Study completedNCT03202667
What this trial is testing

Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study

Who this might be right for
SIAD - Syndrome of Inappropriate AntidiuresisHyponatremia
University Hospital, Basel, Switzerland 17
Not applicableStudy completedNCT04119206
What this trial is testing

Tolvaptan Versus Fluid Restriction in SIADH

Who this might be right for
HyponatremiaSyndrome of Inappropriate ADH (SIADH) SecretionPituitary
University of Erlangen-Nürnberg Medical School 334
Testing effectiveness (Phase 2)Ended earlyNCT01386372
What this trial is testing

Tolvaptan for In-hospital Hyponatremia

Who this might be right for
Hyponatremia
Mario Negri Institute for Pharmacological Research 3
Not applicableStudy completedNCT00390962
What this trial is testing

The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)

Who this might be right for
StrokeTransient Ischemic Attack
University Hospital, Basel, Switzerland 469
Not applicableStudy completedNCT02573077
What this trial is testing

An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy

Who this might be right for
HyponatremiaSyndrome of Inappropriate ADH (SIADH) SecretionCancer
Otsuka Pharmaceutical Europe Ltd 69
Not applicableStudy completedNCT06277336
What this trial is testing

Effects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIAD

Who this might be right for
SIAD - Syndrome of Inappropriate AntidiuresisHyponatremia
University Hospital, Basel, Switzerland 15
Testing effectiveness (Phase 2)Ended earlyNCT04588207
What this trial is testing

Urea for Chronic Hyponatremia

Who this might be right for
HyponatremiaInappropriate ADH Syndrome
Helbert Rondon Berrios, MD, MS 2
Large-scale testing (Phase 3)Study completedNCT00072683
What this trial is testing

"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

Who this might be right for
HyponatremiasWater IntoxicationInappropriate ADH Syndrome+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 205
Not applicableUnknownNCT04409626
What this trial is testing

Hyponatraemia and Mortality in Schizophrenic and Bipolar Patients: Protocol for a Bayesian Causal Inference Study

Who this might be right for
HyponatremiaSIADH
Zealand University Hospital 31,740
Testing effectiveness (Phase 2)Study completedNCT00032734
What this trial is testing

Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

Who this might be right for
Syndrome of Inappropriate ADH (SIADH) SecretionHyponatremia
Sanofi 35
Not applicableLooking for participantsNCT06821802
What this trial is testing

Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis

Who this might be right for
HyponatremiaSyndrome of Inappropriate Antidiuresis
University Hospital, Basel, Switzerland 70
Not applicableStudy completedNCT01465672
What this trial is testing

Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis

Who this might be right for
Pituitary Adenoma
University Hospital, Basel, Switzerland 125
Not applicableStudy completedNCT02545101
What this trial is testing

An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH

Who this might be right for
HyponatremiaSyndrome of Inappropriate ADH (SIADH) Secretion
Otsuka Pharmaceutical Europe Ltd 100
Large-scale testing (Phase 3)Study completedNCT03048747
What this trial is testing

Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH

Who this might be right for
Syndrome of Inappropriate Antidiuretic Hormone Secretion
Otsuka Pharmaceutical Co., Ltd. 16
Not applicableUnknownNCT06171100
What this trial is testing

Low-dose Tolvaptan for Inpatient Hyponatraemia.

Who this might be right for
HyponatremiaSIADH
King's College Hospital NHS Trust 180
Large-scale testing (Phase 3)Study completedNCT02874807
What this trial is testing

Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study

Who this might be right for
SIADH
University Hospital, Basel, Switzerland 88
Large-scale testing (Phase 3)Study completedNCT00264914
What this trial is testing

Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

Who this might be right for
Inappropriate ADH SyndromeHyponatremia
Sanofi 57
Large-scale testing (Phase 3)Study completedNCT00201994
What this trial is testing

Study of Ascending Levels of Tolvaptan in Hyponatremia

Who this might be right for
Hyponatremia
Otsuka Pharmaceutical Development & Commercialization, Inc. 243
Next Page